EVI and Hilleman Lab partner to assess Shigella vaccine EP News Bureau Oct 8, 2019 ShigOraVax will be the first-ever Indian vaccine developed to benefit people living in low and middle-income settings.
Hilleman Laboratories’ preclinical trial report on Hib vaccine offers hope to millions of children Usha Sharma Jun 30, 2015 The unique formulation will not only be cost effective but also scalable for commercial manufacturing Global vaccine research and…
Hilleman Laboratories’ Thermostable technology extends its support towards other vaccines Usha Sharma Apr 23, 2015 The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020
